Importantly, inhibition of the NLRP3 inflammasome or supplementation with NAC attenuated the opioid-induced cerebrovascular dysfunction and ischemic stroke lesions, as well as enhanced poststroke recovery, indicating the effectiveness of a targeted anti-inflammatory intervention for stroke treatment. This evidence concerns the gene NLRP3 and ischemic stroke.